High-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment of recurrent medulloblastoma in children
Open Access
- 8 July 2024
- journal article
- Published by Science for Children Foundation in Pediatric Hematology/Oncology and Immunopathology
- Vol. 23 (2) , 40-46
Abstract
Medulloblastoma (MB) recurrence can manifest in various clinical ways and still remains a major therapeutic challenge. As reported in the international literature, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation (auto-HSCT) has low effectiveness and severe toxicity in patients with recurrent MB. Here, we analyzed the effectiveness and tolerability of HDCT with auto-HSCT in 9 pediatric and adolescent patients with MB relapses whose histological samples and magnetic resonance images had been reviewed at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology from July 2013 till December 2021. The aim of the study was to evaluate the effectiveness of the HDCT with auto-HSCT approach for the treatment of MB relapses in pediatric patients. The study was approved by the Independent Ethics Committee and the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of Russia.Keywords
This publication has 6 references indexed in Scilit:
- Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic ApproachCancers, 2022
- Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyCancers, 2022
- Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 studyJournal of Neuro-Oncology, 2016
- Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumorsPediatric Blood & Cancer, 2011
- High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastomaNeuro-Oncology, 2010
- No Salvage Using High-Dose Chemotherapy Plus/Minus Reirradiation for Relapsing Previously Irradiated MedulloblastomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009